The company manufactures and distributes a range of high-quality solid form liposome food supplements made from natural formulation, most of which are vegan and free from GMOs, soya, and preservatives, operating internationally.
Priding itself on its exceptional products and large, loyal customer base, the efficacy of the company’s products is backed by clinical studies that have demonstrated their superior performance compared to alternatives.
The business is being offered for sale to enable the Shareholders to pursue other unrelated interests.
Offers invited.
Key Highlights
• Operating on a B2B and B2C basis, the company experiences a high rate of return custom, with circa 80% of customers providing ongoing, repeat business.
• Primarily serves customers across the UK, France, and Lithuania.
• Benefits from a large number of online accounts and a range of partnerships with prestigious industry organisations and health professionals.
• Highly skilled management employee in place that can take over the Director’s responsibilities post-sale.
• Operates from leasehold premises.
• Expanding the company’s product range to include specialist programs for beauty and sports consumers and smaller doses could considerably increase revenue.
Financial Highlights
• Turnover of £720k in YE23 with an adjusted EBITDA of £250k.
• Projected turnover of £750k in YE24 with an adjusted EBITDA of £275k.
